Items where authors include "Chalmers, J."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Gharibzadeh, S., Routen, A., Razieh, C. et al. (1382 more authors) (2025) Long term health outcomes in people with diabetes 12 months after hospitalisation with COVID-19 in the UK: a prospective cohort study. eClinicalMedicine, 79. 103005. ISSN 2589-5370

Sach, T.H., Williams, H.C., Allen, H. et al. (23 more authors) (2024) Practicality, validity and responsiveness of using the proxy version of the CHU-9D with children aged 2 to 5 years. Value in Health, 27 (12). pp. 1771-1778. ISSN 1098-3015

Taquet, M., Skorniewska, Z., De Deyn, T. et al. (1085 more authors) (2024) Cognitive and psychiatric symptom trajectories 2–3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK. The Lancet Psychiatry, 11 (9). P696-708. ISSN 2215-0366

Lawson, C.A., Moss, A.J., Arnold, J.R. et al. (1341 more authors) (2024) Long COVID and cardiovascular disease: a prospective cohort study. Open Heart, 11 (1). e002662. ISSN 2053-3624

Lawson, C.A. orcid.org/0000-0003-0127-5236, Moss, A.J. orcid.org/0000-0003-4123-2070, Arnold, J.R. et al. (34 more authors) (2024) Long COVID and cardiovascular disease: a prospective cohort study. Open Heart, 11 (1). e002662. ISSN 2053-3624

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Dixon, G. orcid.org/0000-0001-9787-0739, Hague, S., Mulholland, S. et al. (71 more authors) (2024) Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK. ERJ Open Research, 10 (1). ISSN 2312-0541

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Nguyen, T.N., Harris, K., Woodward, M. et al. (14 more authors) (2021) The impact of frailty on the effectiveness and safety of intensive glucose control and blood pressure–lowering therapy for people with type 2 diabetes : results from the ADVANCE trial. Diabetes Care, 44 (7). pp. 1622-1629. ISSN 0149-5992

van der Leeuw, J., Visseren, F.L.J., Woodward, M. et al. (9 more authors) (2016) Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes. Diabetologia, 59 (12). pp. 2603-2612. ISSN 0012-186X

Danby, S.G. orcid.org/0000-0001-7363-140X, Chalmers, J., Brown, K. et al. (2 more authors) (2016) A functional mechanistic study of the effect of emollients on the structure and function of the skin barrier. British Journal of Dermatology, 175 (5). pp. 1011-1019. ISSN 0007-0963

Woodward, M., Patel, A., Zoungas, S. et al. (9 more authors) (2011) Does Glycemic Control Offer Similar Benefits Among Patients With Diabetes in Different Regions of the World? Results from the ADVANCE trial. Diabetes Care, 34 (12). pp. 2491-2495. ISSN 0149-5992

Zoungas, S., de Galan, B.E., Ninomiya, T. et al. (10 more authors) (2009) Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes: New results from the ADVANCE trial. Diabetes Care, 32 (11). pp. 2068-2074. ISSN 0149-5992